Literature DB >> 11091116

Humoral factors in intestinal adaptation.

L Baksheev1, P J Fuller.   

Abstract

The small bowel has a remarkable ability to adapt after injury, inflammation or resection. It has long been suggested that humoral factors, particularly enteroglucagon, epidermal growth factor, neurotensin and growth hormone/insulin-like growth factor I, might stimulate bowel growth. Of particular interest is the recent finding that glucagon-like peptide 2 (GLP-2), a product of the gene encoding proglucagon, exerts a trophic effect on the intestinal epithelium via a specific G-protein-coupled receptor. GLP-2 and/or these other trophic peptides might prove to have a role in the treatment of bowel diseases associated with structural or functional loss of the small bowel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091116     DOI: 10.1016/s1043-2760(00)00307-6

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  9 in total

1.  Plasma GLP-2 levels and intestinal markers in the juvenile pig during intestinal adaptation: effects of different diet regimens.

Authors:  Monique C Paris; Peter J Fuller; Bendix Carstensen; Eva Nagy; Russell G Taylor; Magdy Sourial; Jens J Holst; Bolette Hartmann; Julie E Binesm
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 2.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

3.  Administration of a dipeptidyl peptidase IV inhibitor enhances the intestinal adaptation in a mouse model of short bowel syndrome.

Authors:  Manabu Okawada; Jens J Holst; Daniel H Teitelbaum
Journal:  Surgery       Date:  2011-06-30       Impact factor: 3.982

4.  Gene expression in the adapting small bowel after massive small bowel resection.

Authors:  Lyrissa Baksheev; Peter J Fuller
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

5.  Medical and surgical management of the pediatric patient with intestinal failure.

Authors:  Frances R Malone; Simon P Horslen
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10

6.  Evidence for the absence of an intestinal adaptive mechanism to compensate for C. parvum-induced amino acid malabsorption in suckling rats.

Authors:  A Topouchian; J F Huneau; L Barbot; S Rome; J G Gobert; D Tomé; N Kapel
Journal:  Parasitol Res       Date:  2003-08-16       Impact factor: 2.289

7.  Effect of growth hormone on small intestinal homeostasis relation to cellular mediators IGF-I and IGFBP-3.

Authors:  Betul Ersoy; Kemal Ozbilgin; Erhun Kasirga; Sevinc Inan; Senol Coskun; Ibrahim Tuglu
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

8.  The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.

Authors:  Francesco Russo; Michele Linsalata; Caterina Clemente; Benedetta D'Attoma; Antonella Orlando; Giovanna Campanella; Francesco Giotta; Giuseppe Riezzo
Journal:  BMC Cancer       Date:  2013-02-04       Impact factor: 4.430

9.  Bombesin stimulates enterocyte turnover following massive small bowel resection in a rat.

Authors:  Igor Sukhotnik; Nadav Slijper; Rachel Karry; Ron Shaoul; Arnold G Coran; Michael Lurie; Eitan Shiloni; Jorge G Mogilner
Journal:  Pediatr Surg Int       Date:  2007-05       Impact factor: 2.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.